Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

KemPharm Inc at the RBC Capital Markets 2017 Global Healthcare

Feb 22, 2017 from 9:00 AM to 9:00 AM EST


The New York Palace Hotel